Advertisement

Topics

FDA Approves Long-acting Injectable for Bipolar Disorder

07:35 EDT 31 Jul 2017 | Medscape

The FDA has approved extended-release injectable aripiprazole for maintenance monotherapy for bipolar disorder in adults.
FDA Approvals

Original Article: FDA Approves Long-acting Injectable for Bipolar Disorder

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Long-acting Injectable for Bipolar Disorder"

Quick Search
Advertisement
 

Relevant Topic

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...